Clinical Characteristics of Breast Cancers in African‐American Women with Benign Breast Disease: A Comparison to the Surveillance,Epidemiology, and End Results Program |
| |
Authors: | Susanna D. Mitro MPH Rouba Ali‐Fehmi MD Sudeshna Bandyopadhyay MD Baraa Alosh MD Bassam Albashiti MD Derek C. Radisky PhD Marlene H. Frost PhD Amy C. Degnim MD Julie J. Ruterbusch MPH Michele L. Cote PhD |
| |
Affiliation: | 1. School of Public Health, University of Michigan, , Ann Arbor, Michigan;2. Department of Pathology, Wayne State University, , Detroit, Michigan;3. Division of Biochemistry/Molecular Biology, Mayo Clinic in Jacksonville, , Jacksonville, Florida;4. Department of Medical Oncology, Mayo Clinic, , Rochester, Minnesota;5. Department of Surgery, Mayo Clinic, , Rochester, Minnesota;6. Department of Oncology, Wayne State University, , Detroit, Michigan;7. Karmanos Cancer Institute, Population Studies and Disparities Research Program, , Detroit, Michigan |
| |
Abstract: | Benign breast disease (BBD) is a very common condition, diagnosed in approximately half of all American women throughout their lifecourse. White women with BBD are known to be at substantially increased risk of subsequent breast cancer; however, nothing is known about breast cancer characteristics that develop after a BBD diagnosis in African‐American women. Here, we compared 109 breast cancers that developed in a population of African‐American women with a history of BBD to 10,601 breast cancers that developed in a general population of African‐American women whose cancers were recorded by the Metropolitan Detroit Cancer Surveillance System (MDCSS population). Demographic and clinical characteristics of the BBD population were compared to the MDCSS population, using chi‐squared tests, Fisher's exact tests, t‐tests, and Wilcoxon tests where appropriate. Kaplan–Meier curves and Cox regression models were used to examine survival. Women in the BBD population were diagnosed with lower grade (p = 0.02), earlier stage cancers (p = 0.003) that were more likely to be hormone receptor‐positive (p = 0.03) compared to the general metropolitan Detroit African‐American population. In situ cancers were more common among women in the BBD cohort (36.7%) compared to the MDCSS population (22.1%, p < 0.001). Overall, women in the BBD population were less likely to die from breast cancer after 10 years of follow‐up (p = 0.05), but this association was not seen when analyses were limited to invasive breast cancers. These results suggest that breast cancers occurring after a BBD diagnosis may have more favorable clinical parameters, but the majority of cancers are still invasive, with survival rates similar to the general African‐American population. |
| |
Keywords: | African‐American benign breast disease breast cancer risk survival |
|
|